Florealis is a pharmaceutical company providing solutions for people that want to use high quality herbal medicinal products to stay healthy. Our medicines are natural products based on long experience as well as scientific evidence and are approved by European health authorities.
We make reliable herbal medicine according to the highest standards in the pharmaceutical industry. In our pipelines are medicines for treatment of mild common symptoms and disease, such as recurrent lower urinary tract infections, of spasmodic gastrointestinal complaints, the relief of temporary mental exhaustion or stress. Our products will be sold in pharmacies and are available without a prescription.
Herbal medicines are products that bridge the gap between unregistered and uncontrolled herbal remedies and conventional medicines. Our aim is to use the best of both; standardized active herbal ingredients combined with quality and safety requirements from the pharmaceutical industry.
Kolbrún has a solid background within the pharmaceutical industry and has an extensive knowledge of drug development. Her experience in business strategy and international business development are essential part of her contribution to the team. She believes that key success factors in business are clear goals, good planning and effective teamwork.
Karl has extensive experience in sales, marketing, product management and brand building within the medical field. In recent years he has been an executive in international medical device companies such as Ossur, Biomet and Ekso Bionics. Karl has lead several successful efforts in bringing new medical technologies and products to the markets, both in Europe and the US.
Elsa holds a M.Sc. degree in Pharmacy and Ph.D. degree in Natural Product Chemistry from the University of Iceland. She has experience from both the academy and pharmaceutical industry. Before joining Florealis she worked in the R&D department of Actavis as a clinical scientist, with earlier experience as a project manager and stability scientist.